Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Electric muscle training may tame high blood pressure without pills

NCT ID NCT07406191

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether whole-body electromyostimulation (WB-EMS), a technology that stimulates muscles with mild electrical pulses, can lower resting blood pressure and improve other heart risk factors in overweight adults aged 50+ with mild hypertension. Over 12 weeks, 28 participants either received WB-EMS twice a week for 20 minutes or continued their normal routine. The goal is to see if this time-saving, joint-friendly training can be a safe and effective option for managing blood pressure and metabolic health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Whole-body electromyostimulation (WB-EMS)
What this could lead to
If it works, this could offer a time-efficient, joint-friendly exercise alternative to help manage blood pressure and other heart risk factors.
What could go wrong
This is a small, early-stage study with only 28 participants, so results may not apply widely. WB-EMS is not a substitute for medication or lifestyle changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

28 people

The number who actually took part.

Started

Feb 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 70 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Grade 1 hypertension: systolic 140 and/or diastolic 90 mmHg * overweight or obese (body mass index \> 25 kg/m2) Exclusion Criteria: * blood pressure-lowering pharmacologic therapy. * WB-EMS application and regular resistance exercise training * Conditions and illnesses that preclude intensive physical exertion * Severe cardiac arrhythmia * Heart failure * acute pulmonary embolism * acute myocarditis * severe hypertension, e.g. blood pressure \> 200 mmHg systolic and/or \>110 mmHg diastolic * Contraindications for bioimpedance analysis (e.g. pacemaker) * Contraindications for WB-EMS application (e.g. acute infections/fever, epilepsy)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypercholesterolemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Faculty of Medicine, University of Tuebingen

    Erlangen, 91052, Germany

  • Institute of Radiology, University Hospital Erlangen

    Erlangen, 91054, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.